CJC-1295 No DAC (10 mg) + Ipamorelin (5 mg) Research Peptide Blend

Ipamorelin 5mg: What to Check Before You Buy

Ipamorelin – 5 mg is one of the most consistently searched vial sizes in the growth-hormone-secretagogue peptide category, often alongside CJC-1295 in combination listings. Before comparing suppliers, it’s worth understanding exactly what the compound is, what distinguishes a well-documented vial from a poorly documented one, and why combination products need extra scrutiny.

Research use only. Ipamorelin and CJC-1295 are sold for laboratory research. They are not medicines, supplements or foods, and are not intended for human or veterinary use.

What Is Ipamorelin?

Ipamorelin 5 mg listings refer to a synthetic pentapeptide studied as a selective growth hormone secretagogue receptor (GHS-R1a) agonist. Unlike earlier-generation secretagogues, research interest in Ipamorelin centres on its selectivity — investigated for stimulating growth hormone release with comparatively less effect on cortisol, prolactin and ACTH than some other compounds in this class.

Key identifiers:

• CAS number: 170851-70-4
• Receptor target: GHS-R1a (selective agonist)
• Compound class: synthetic pentapeptide, growth hormone secretagogue
• Form: lyophilised powder
• Purity standard: >99% HPLC is achievable and worth benchmarking against

What Is CJC-1295, and Why Is It Sold With Ipamorelin?

CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue, often paired with Ipamorelin in combination listings because the two are studied as acting on different points in the same signalling pathway; CJC-1295 on GHRH receptors, Ipamorelin on the GHS-R1a receptor. That’s the scientific rationale suppliers cite for selling them together, but it’s worth being clear-eyed about what that means: research on the two compounds individually doesn’t automatically establish how they behave in combination, and any specific claims about a combined effect should be checked against genuine primary literature rather than taken on a supplier’s word.

CJC 1295 7.5mg Ipamorelin 15mg and Similar Blend Ratios

Combination vials appear in a range of stated ratios, and CJC 1295 7.5 mg Ipamorelin 15mg is one such listing you may encounter alongside more common 5mg/5mg pairings. When comparing blend ratios:

1. Confirm the exact milligram split is stated for each compound, not just a combined total
2. Check whether the ratio matches a documented rationale or is simply a marketing variation
3. Request a COA covering both compounds separately, since purity and identity testing for a blend needs to verify each active ingredient, not just an aggregate
4. Be sceptical of unusual ratios with no stated reasoning — a 7.5mg/15mg split should have a clear explanation from the supplier, not just exist because it’s a differentiator

CJC-1295/Ipamorelin 5/5mg: What a Standard Blend Should Include

CJC 1295 / Ipamorelin 5/5 mg (also written CJC 1295 Ipamorelin 5 5 mg) is the most common combination ratio on the UK market, an equal split of both compounds. For this or any blend format, a credible listing should specify:

How to Choose a Supplier

1. Check for third-party COA, not just an in-house certificate — Precision Peptides’ approach of stating “>99% HPLC purity, third-party COA included” directly on the product page is the standard worth looking for
2. Verify CAS numbers independently against chemical databases rather than trusting the listing alone
3. Confirm UK dispatch and storage practices, since both compounds are typically stored frozen and are sensitive to temperature fluctuation in transit
4. Avoid any site offering stacking advice, injection schedules or “protocol” content — this is a clear signal the supplier is marketing toward self-administration rather than genuine research use, regardless of the “research use only” disclaimer attached
5. Compare blend ratios carefully rather than assuming all “CJC-1295/Ipamorelin” listings are equivalent

Storage and Handling

• Store lyophilised powder at -20°C, protected from light and moisture
• Once reconstituted, storage conditions and stability windows vary by formulation, follow the specific product’s documentation rather than a generic figure
• Avoid repeated freeze-thaw cycles
• For blends, confirm whether both compounds share the same reconstitution and storage requirements, since combination products sometimes have compound-specific handling notes

Supplier Comparison at a Glance

Frequently Asked Questions

Is Ipamorelin the same whether bought alone or in a CJC-1295 blend?
It should be the same compound, but always check that a blend product states Ipamorelin’s individual purity and identity separately, not just an aggregate figure for the vial.

Why do CJC-1295/Ipamorelin ratios vary between suppliers?
Different suppliers offer different combination ratios (5mg/5mg being most common). There’s no single standard, so check that any stated ratio comes with a clear rationale rather than assuming it’s interchangeable with others.

Is there an established human dose for these compounds?
No completed, approved human dosing protocol applies to unregulated research-grade Ipamorelin or CJC-1295. Treat any site providing specific dosing or injection schedules with caution, regardless of how it’s framed.

What should come with my order?
A labelled vial with a batch number, and access to a third-party COA confirming purity and identity for each compound present.

Final Thoughts

Ipamorelin and CJC-1295 are genuinely well-characterised compounds in the research literature, but the online market around them is crowded with low-quality, self-administration-oriented content. Choose a supplier that documents purity and identity per compound, states CAS numbers plainly, and keeps to research-use framing without stacking advice or dosing schedules.